https://health-fitness.news-articles.net/content/2016/11/02/new-data-from-pivotal-ra-beacon-study-show-significant-improvement-in-patient-reported-outcomes-in-rheumatoid-arthritis-patient.html2016-11-02T07:41:00+00:00 https://health-fitness.news-articles.net/content/2016/11/03/lilly-presents-clinical-efficacy-safety-and-patient-reported-outcomes-data-of-baricitinib-in-patients-with-rheumatoid-arthriti.html2016-11-03T07:22:00+00:00 https://health-fitness.news-articles.net/content/2016/11/09/columbus-phase-3-study-results-in-braf-mutant-melanoma-presented-at-society-for-melanoma-research-annual-congress.html2016-11-09T07:00:00+00:00 https://health-fitness.news-articles.net/content/2016/11/13/jardiance-empagliflozin-consistently-reduced-the-risk-of-cardiovascular-death-in-adults-with-type-2-diabetes-regardless-of-th.html2016-11-13T12:00:00+00:00 https://health-fitness.news-articles.net/content/2016/11/14/new-analyses-of-phase-3-trials-show-improvements-in-rheumatoid-arthritis-symptoms-following-treatment-with-baricitinib-across-d.html2016-11-14T06:00:00+00:00 https://health-fitness.news-articles.net/content/2016/11/14/baricitinib-demonstrates-early-response-compared-to-placebo-and-significant-improvement-compared-to-adalimumab-in-patient-repor.html2016-11-14T06:00:00+00:00 https://health-fitness.news-articles.net/content/2016/11/23/lilly-announces-top-line-results-of-solanezumab-phase-3-clinical-trial.html2016-11-23T03:45:00+00:00